Atherogenic Oxidized Low-Density Lipoprotein/β2-Glycoprotein I (oxLDL/β2GPI) Complexes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Lupus

• Publication date

  2006-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1191/0961203306lu2337oaPMID 16898186
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxidized low-density lipoprotein and β2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis

  2006cited by this paper
• Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.

  2005cited by this paper
• Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.

  2005cited by this paper
• OxLDL/β2GPI Complexes and Autoantibodies in Patients with Systemic Lupus Erythematosus, Systemic Sclerosis, and Antiphospholipid Syndrome: Pathogenic Implications for Vascular Involvement

  2005cited by this paper
• Are Anti–Oxidized Low-Density Lipoprotein Antibodies Pathogenic or Protective?

  2004cited by this paper
• Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.

  2004cited by this paper
• Oxidized Low-Density Lipoprotein/β2-Glycoprotein I Complexes and Autoantibodies to oxLig-1/β2-Glycoprotein I in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome

  2004cited by this paper
• Autoimmunity: busting the atherosclerotic plaque

  2003cited by this paper
• IgG Autoantibodies against β2-Glycoprotein I Complexed with a Lipid Ligand Derived from Oxidized Low-Density Lipoprotein are Associated with Arterial Thrombosis in Antiphospholipid Syndrome

  2003cited by this paper
• Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen.

  2003cited by this paper
• Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome

  2003cited by this paper
• ω-Carboxyl variants of 7-ketocholesteryl esters are ligands for β2-glycoprotein I and mediate antibody-dependent uptake of oxidized LDL by macrophages DOI 10.1194/jlr.M20063-JLR200

  2002cited by this paper
• Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL.

  2002cited by this paper
• Omega-carboxyl variants of 7-ketocholesteryl esters are ligands for beta(2)-glycoprotein I and mediate antibody-dependent uptake of oxidized LDL by macrophages.

  2002cited by this paper
• Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime

  2002cited by this paper
• Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.

  2002cited by this paper
• Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.

  2001cited by this paper
• A specific ligand for beta(2)-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages.

  2001cited by this paper
• &bgr;2-Glycoprotein 1–Dependent Anticardiolipin Antibodies and Risk of Ischemic Stroke and Myocardial Infarction: The Honolulu Heart Program

  2001cited by this paper
• Epidemiology of cardiovascular disease in systemic lupus erythematosus

  2000cited by this paper
• Paraoxonase activity is dramatically decreased in patients positive for anticardiolipin antibodies

  2000cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Immunolocalization of (cid:98) 2 -Glycoprotein I (Apolipoprotein H) to Human Atherosclerotic Plaques Potential Implications for Lesion Progression Brief Rapid Communication

  1999cited by this paper
• Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus.

  1999cited by this paper
• HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Ongoing Prothrombotic State in Patients With Antiphospholipid Antibodies : A Role for Increased Lipid Peroxidation

  1999cited by this paper
• International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.

  1999cited by this paper
• Oxidative stress in systemic lupus erythematosus and allied conditions with vascular involvement.

  1999cited by this paper
• Antiphospholipid antibodies and myocardial infarction

  1998cited by this paper
• Involvement of β2‐glycoprotein I and anticardiolipin antibodies in oxidatively modified low‐density lipoprotein uptake by macrophages

  1997cited by this paper
• Oxidized low‐density lipoprotein (Ox‐LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS)

  1997cited by this paper
• beta 2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome.

  1994cited by this paper
• Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes.

  1993cited by this paper
• Autoantibody against oxidised LDL and progression of carotid atherosclerosis.

  1992cited by this paper
• Anticardiolipin antibodies in NZW x BXSB F1 mice. A model of antiphospholipid syndrome.

  1992cited by this paper
• Oxidative modification of LDL: comparison between cell-mediated and copper-mediated modification.

  1990cited by this paper
• Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.

  1989cited by this paper
• The 1982 revised criteria for the classification of systemic lupus erythematosus.

  1982cited by this paper
• [Erythematosus].

  1971cited by this paper
• Separation of subfractions of human beta-2-glycoprotein I.

  1967cited by this paper
• Separation of subfractions of human β2-glycoprotein I

  1967cited by this paper
• The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

  1955cited by this paper

• Statins as an Adjunctive Antithrombotic Agent in Thrombotic Antiphospholipid Syndrome: Mechanisms and Clinical Implications

  2025cites this paper
• Scavenger receptors: key players in the immunological puzzle of lupus

  2025cites this paper
• Antiphospholipid antibodies are associated with increased levels of selected oxidative stress biomarkers

  2025cites this paper
• Oxidative Stress as a Regulatory Checkpoint in the Production of Antiphospholipid Autoantibodies: The Protective Role of NRF2 Pathway

  2023cites this paper
• Antibodies against phosphorylcholine and protection against atherosclerosis, cardiovascular disease and chronic inflammation

  2022cites this paper
• Oxidative Stress in the Pathogenesis of Antiphospholipid Syndrome: Implications for the Atherothrombotic Process

  2021cites this paper
• The characteristics of clinical laboratory indicators in anticardiolipin antibody positive cerebral infarction patients.

  2021cites this paper
• New insights into the pathogenic mechanisms and treatment of arterial thrombosis in antiphospholipid syndrome

  2020cites this paper
• Morbidity and mortality in antiphospholipid syndrome based on cluster analysis: a 10-year longitudinal cohort study.

  2020cites this paper
• IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.

  2016cites this paper
• Role of apolipoprotein B100 and oxidized low-density lipoprotein in the monocyte tissue factor induction mediated by anti-β2 glycoprotein I antibodies

  2016cites this paper
• oxLDL/β2GPI/anti-β2GPI complex induced macrophage differentiation to foam cell involving TLR4/NF-kappa B signal transduction pathway.

  2014cites this paper
• The relationship between antibeta 2 glycoprotein antibodies and SYNTAX score in patients undergoing coronary artery by-pass graft surgery.

  2014cites this paper
• The Role of Siglec-1 and SR-BI Interaction in the Phagocytosis of Oxidized Low Density Lipoprotein by Macrophages

  2013cites this paper
• Anti-ox-LDL antibodies and anti-ox-LDL-B2GPI antibodies in patients with systemic lupus erythematosus.

  2012cites this paper
• Anti-Ox-LDL Antibodies and Anti-Ox-LDL-B 2 GPI Antibodies in Patients with Systemic Lupus Erythematosus Przeciwciała przeciwko oksydowanym LDL oraz przeciwko kompleksom oxLDL-β2GPI u chorych na tocznia rumieniowatego układowego

  2012cites this paper
• Targeted interception of signaling reactive oxygen species in the vascular endothelium.

  2012cites this paper
• Studies on cardiovascular risk factors in Systemic Lupus Erythematosus

  2012cites this paper
• Taming lupus—a new understanding of pathogenesis is leading to clinical advances

  2012cites this paper
• Pathophysiology of the antiphospholipid antibody syndrome

  2011cites this paper
• Apolipoprotein H: its relevance to cardiovascular disease.

  2010cites this paper
• Tese para obtenção do grau de Doutor

  2010cites this paper
• Detection of serum beta(2)-GPI-Lp(a) complexes in patients with systemic lupus erythematosus.

  2010cites this paper
• Management of cardiovascular complications in systemic lupus erythematosus.

  2010cites this paper
• Implicações do polimorfismo Y402H de fator H para a concentração plasmática de proteinas do sistema complemento e do perfil lipídico em pacientes com degeneração da mácula relacionada a idade.

  2009cites this paper
• Thrombophilic patterns of coagulation factors in lupus

  2009cites this paper
• Apolipoprotein H Promoter Polymorphisms in Relation to Lupus and Lupus-related Phenotypes

  2009cites this paper
• A BRIEF COMMUNICATION

  2009cites this paper
• FUNCTIONAL CHARACTERIZATION OF APOLIPOPROTEIN H POLYMORPHISMS AND THEIR RELATION TO SYSTEMIC LUPUS ERYTHEMATOSUS

  2009cites this paper
• Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism.

  2008cites this paper
• Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome?

  2008cites this paper
• The Correlation Between Cytomegalovirus Infection and Coronary Artery Disease

  2007cites this paper
• Accelerated atherosclerosis in systemic lupus erythematosus and other connective tissue diseases

  2007cites this paper
• Novel Aspects of Diagnostic Test: Multiple Autoantigens, New Algorithms and Revolutionary Techniques

  2006cites this paper